pI: 9.9302 |
Length (AA): 877 |
MW (Da): 94910 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
385 | 854 | 1e32 (A) | 27 | 458 | 24.00 | 0 | 1 | 0.6 | 0.48 |
583 | 877 | 1xwi (A) | 124 | 443 | 44.00 | 0 | 1 | 0.83 | -0.84 |
569 | 876 | 3d8b (A) | 377 | 672 | 47.00 | 0 | 1 | 0.831497 | -0.51 |
579 | 871 | 3b9p (A) | 469 | 750 | 53.00 | 0 | 1 | 0.860793 | -0.32 |
579 | 874 | 5wc1 (A) | 174 | 469 | 45.00 | 0 | 1 | 0.673214 | 0.39 |
582 | 818 | 3whk (A) | 171 | 405 | 43.00 | 0 | 1 | 0.693939 | -0.59 |
583 | 876 | 3eih (A) | 123 | 434 | 43.00 | 0 | 1 | 0.802534 | -0.55 |
585 | 858 | 2ce7 (C) | 153 | 429 | 35.00 | 0 | 1 | 0.641729 | 0.05 |
590 | 818 | 5eqt (A) | 103 | 329 | 42.00 | 0 | 1 | 0.687817 | -0.22 |
761 | 818 | 4a3v (B) | 379 | 433 | 27.00 | 0 | 0.99 | 0.474435 | -1.15 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127068)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G45500 | AAA-type ATPase-like protein |
Arabidopsis thaliana | AT3G27120 | P-loop containing nucleoside triphosphate hydrolases superfamily protein |
Babesia bovis | BBOV_I000400 | ATPase, AAA family domain containing protein |
Brugia malayi | Bm1_02420 | ATPase, AAA family protein |
Brugia malayi | Bm1_53365 | ATPase, AAA family protein |
Candida albicans | CaO19.7558 | potential AAA family ATPase similar to S. cerevisiae SAP1 (YER047C) |
Caenorhabditis elegans | CELE_C24B5.2 | Protein SPAS-1, isoform B |
Caenorhabditis elegans | CELE_F32D1.1 | Protein FIGL-1 |
Cryptosporidium hominis | Chro.50096 | AAA family ATPase |
Cryptosporidium parvum | cgd5_2790 | katanin p60/fidgetin family with AAA ATpase |
Dictyostelium discoideum | DDB_G0287165 | AAA ATPase domain-containing protein |
Dictyostelium discoideum | DDB_G0268334 | hypothetical protein |
Drosophila melanogaster | Dmel_CG3326 | CG3326 gene product from transcript CG3326-RB |
Drosophila melanogaster | Dmel_CG5977 | spastin |
Echinococcus granulosus | EgrG_001005200 | fidgetin protein 1 |
Entamoeba histolytica | EHI_036890 | ATPase, Vps4 oligomerisation domain containing protein |
Echinococcus multilocularis | EmuJ_001005200 | fidgetin protein 1 |
Homo sapiens | ENSG00000021574 | spastin |
Homo sapiens | ENSG00000132436 | fidgetin-like 1 |
Leishmania braziliensis | LbrM.15.0500 | katanin-like protein,serine peptidase, Clan SJ, family S16, putative |
Leishmania donovani | LdBPK_150520.1 | katanin-like protein |
Leishmania infantum | LinJ.15.0520 | katanin-like protein,serine peptidase, Clan SJ, family S16, putative |
Leishmania major | LmjF.15.0500 | katanin-like protein,serine peptidase, Clan SJ, family S16, putative |
Leishmania mexicana | LmxM.15.0500 | katanin-like protein,serine peptidase, Clan SJ, family S16, putative |
Loa Loa (eye worm) | LOAG_05931 | fidgetin protein |
Loa Loa (eye worm) | LOAG_04996 | ATPase |
Mus musculus | ENSMUSG00000035455 | fidgetin-like 1 |
Mus musculus | ENSMUSG00000024068 | spastin |
Neospora caninum | NCLIV_055880 | ATPase, AAA family protein, related |
Oryza sativa | 4339999 | Os06g0130000 |
Oryza sativa | 9271031 | Os12g0443800 |
Plasmodium berghei | PBANKA_1005500 | AAA family ATPase, putative |
Plasmodium falciparum | PF3D7_0407900 | AAA family ATPase, putative |
Plasmodium knowlesi | PKNH_0305900 | AAA family ATPase, putative |
Plasmodium vivax | PVX_000850 | AAA family ATPase, putative |
Plasmodium yoelii | PY02232 | ATPase, AAA family, putative |
Saccharomyces cerevisiae | YPL074W | putative AAA family ATPase YTA6 |
Saccharomyces cerevisiae | YER047C | putative AAA family ATPase SAP1 |
Schistosoma japonicum | Sjp_0049080 | ko:K01509 adenosinetriphosphatase [EC3.6.1.3], putative |
Schistosoma mansoni | Smp_002810 | fidgetin like-1 |
Schmidtea mediterranea | mk4.010616.00 | |
Schmidtea mediterranea | mk4.002854.04 | Fidgetin-like protein 1 |
Schmidtea mediterranea | mk4.010616.01 | Fidgetin-like protein 1 |
Schmidtea mediterranea | mk4.001181.02 | Probable spastin homolog spas-1 |
Trypanosoma brucei gambiense | Tbg972.3.1190 | AAA ATPase, putative,Spastin, putative |
Trypanosoma brucei gambiense | Tbg972.5.2570 | hypothetical protein, conserved,serine peptidase, Clan SJ, family S16, putative |
Trypanosoma brucei | Tb927.3.1440 | Spastin, putative |
Trypanosoma brucei | Tb927.5.1870 | metalloprotease, putative |
Trypanosoma congolense | TcIL3000_0_25690 | Spastin, putative |
Trypanosoma congolense | TcIL3000_0_15540 | Spastin, putative |
Trypanosoma congolense | TcIL3000_0_08200 | metalloprotease, putative |
Trypanosoma cruzi | TcCLB.508533.30 | metalloprotease, putative |
Trypanosoma cruzi | TcCLB.509437.50 | Spastin, putative |
Trypanosoma cruzi | TcCLB.509233.70 | AAA ATPase, putative |
Toxoplasma gondii | TGME49_302150 | ATPase, AAA family protein |
Toxoplasma gondii | TGME49_312310 | ATPase, AAA family protein |
Theileria parva | TP02_0917 | AAA family ATPase, putative |
Trichomonas vaginalis | TVAG_339190 | spastin, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.1870 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.1870 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.1870 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.1870 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.3.1440 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.1440 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.1440 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.3.1440 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F32D1.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F32D1.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F32D1.1 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_1005500 | Plasmodium berghei | Dispensable | plasmo |
TGME49_312310 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_302150 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.